Curtis’s connection to lupus is deeply personal—rooted in a commitment to honoring his late daughter, Rashara. After her passing, Curtis and his family transformed their grief into purpose, raising ...

Understanding and choosing the right health insurance can feel overwhelming, especially when managing a chronic condition. Fortunately, there are trusted national and state-based resources that can ...

A new study looked at whether heart scan results can help predict serious cardiovascular or cerebrovascular (brain) events ...

At the 2026 Oscars, comedian Conan O’Brien made a joke during a skit to open the show that negatively associated his appearance with make-up to having lupus. Using lupus as a punchline, especially ...

Disasters can happen any time of the year — from hurricanes, floods, wildfires, snowstorms and more. For people living with lupus, preparing ahead is especially important. Whether it’s knowing how to ...

New analysis of Gazyva® shows the drug significantly reduces disease activity in adults with systemic lupus erythematosus.

Interested in getting research like this straight to your inbox? Subscribe to our monthly Inside Lupus Research email for all the latest.

The U.S. Food and Drug Administration (FDA) issued a complete response letter requesting additional information from AstraZeneca regarding the Biologics License Application (BLA) for subcutaneous (SC) ...

UPDATE: Following Congress' passage, the President signed this legislation into law on Feb. 3, 2026. This afternoon, Congress took the final steps in the FY 2026 budget process, passing legislation ...

The U.S. Food and Drug Administration (FDA) approved Gazyva® to treat adults with lupus nephritis in October 2025. Gazyva targets and removes harmful B cells to help protect the kidneys in people with ...

Both subacute cutaneous lupus and discoid lupus are a form of lupus skin disease, though they have some distinct differences. Subacute cutaneous lupus may show up as ring-shaped red, scaly lesions.

A new groundbreaking study has recently identified the link between the long-standing mystery in autoimmune disease: Epstein-Barr Virus (EBV) and how it contributes towards the development of systemic ...